Indianapolis, IN, United States of America

Shelia P Little

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shelia P Little. Retrieved from https://idiyas.com/inventor/shelia-p-little

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shelia P Little

Introduction

Shelia P Little is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel DNA compounds that encode human protein C activity. Her work has implications for the treatment and prevention of various vascular disorders.

Latest Patents

Shelia P Little holds a patent for "Vectors and compounds for expression of human protein C." This invention comprises novel DNA compounds that drive the expression of protein C activity when transformed into an appropriate host cell. The recombinant-produced protein C activity is useful in treating and preventing a variety of vascular disorders.

Career Highlights

Shelia is currently employed at Eli Lilly and Company, where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing the understanding and application of protein C derivatives and precursors.

Collaborations

Some of her notable coworkers include Nils U Bang and Robert J Beckmann, who have collaborated with her on various projects within the company.

Conclusion

Shelia P Little's contributions to biotechnology through her patent and work at Eli Lilly and Company highlight her role as an influential inventor in the field. Her innovations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…